Boxes of Ozempic and Wegovy made by Novo Nordisk are seen astatine a pharmacy.
Hollie Adams | Reuters
Shares of Danish pharmaceutical elephantine Novo Nordisk plummeted much than 24% connected Friday, putting it connected people for its worst-ever regular loss, aft reporting results successful a late-stage proceedings for its experimental CagriSema value nonaccomplishment cause that missed expectations.
The shaper of the wildly fashionable Wegovy obesity cause said its caller cause campaigner helped patients trim their value by 22.7%, beneath the 25% it had forecast, according to Reuters.
The banal was trading down 22% astatine 11:24 a.m. London time.
This is simply a breaking quality story. Please cheque backmost for updates.
English (US)